| Product Code: ETC7661126 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Rivaroxaban Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Rivaroxaban Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Rivaroxaban Market - Industry Life Cycle |
3.4 Israel Rivaroxaban Market - Porter's Five Forces |
3.5 Israel Rivaroxaban Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Israel Rivaroxaban Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Rivaroxaban Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Israel |
4.2.2 Growing awareness about the benefits of using Rivaroxaban for stroke prevention |
4.2.3 Favorable government policies promoting the use of anticoagulants |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval process for new drugs in Israel |
4.3.2 Competition from other anticoagulant drugs in the market |
4.3.3 High cost associated with Rivaroxaban leading to affordability issues for some patients |
5 Israel Rivaroxaban Market Trends |
6 Israel Rivaroxaban Market, By Types |
6.1 Israel Rivaroxaban Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Israel Rivaroxaban Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Israel Rivaroxaban Market Revenues & Volume, By Acute coronary syndrome, 2021- 2031F |
6.1.4 Israel Rivaroxaban Market Revenues & Volume, By Pulmonary embolism, 2021- 2031F |
6.1.5 Israel Rivaroxaban Market Revenues & Volume, By Venous thromboembolism, 2021- 2031F |
6.1.6 Israel Rivaroxaban Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Rivaroxaban Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Israel Rivaroxaban Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Israel Rivaroxaban Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 Israel Rivaroxaban Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Rivaroxaban Market Import-Export Trade Statistics |
7.1 Israel Rivaroxaban Market Export to Major Countries |
7.2 Israel Rivaroxaban Market Imports from Major Countries |
8 Israel Rivaroxaban Market Key Performance Indicators |
8.1 Number of prescriptions for Rivaroxaban in Israel |
8.2 Patient adherence rate to Rivaroxaban treatment |
8.3 Number of clinical trials and studies conducted on Rivaroxaban in Israel |
9 Israel Rivaroxaban Market - Opportunity Assessment |
9.1 Israel Rivaroxaban Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Israel Rivaroxaban Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Rivaroxaban Market - Competitive Landscape |
10.1 Israel Rivaroxaban Market Revenue Share, By Companies, 2024 |
10.2 Israel Rivaroxaban Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here